ArticleFacts, views & vision in ObGyn2026
Finis coronat opus? What comes after hysteroscopic metroplasty.
Article in Facts, views & vision in ObGyn, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hysteroscopic metroplasty is widely regarded as the endpoint of septate uterus care, yet its impact on fertility remains uncertain and the postoperative cavity is seldom reassessed. Evidence on second-look hysteroscopy is equally scarce: mostly retrospective, rarely randomised, and not designed to isolate its reproductive effect. Re-inspection should arguably be reframed as an integral, fertility-oriented step rather than optional surveillance. Routine use in all patients is unjustified and not cost-effective, yet systematic omission may also overlook clinically relevant abnormalities. A selective, risk-stratified strategy is preferable, reserving it for the highest-risk women and triaging the rest with three-dimensional sonohysterography. Prospective, second-look-controlled trials are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.